Category: Latest News
-
Dow Jones, S&P, Nasdaq Futures Signal Flat Start as Trade Concerns Linger
Futures for the major U.S. stock indexes are pointing toward a mostly unchanged open on Thursday, suggesting a pause after gains in the previous session. Uncertainty surrounding President Donald Trump’s trade policy stance continues to weigh on investor sentiment, keeping some traders cautious amid ongoing threats of tariff hikes across various industries and countries. “Trump…
-
U.S. First-Time Unemployment Claims Unexpectedly Decline
Initial applications for U.S. unemployment benefits saw a surprising slight drop during the week ending July 5, according to Thursday’s Labor Department report. The data revealed that first-time claims fell to 227,000, down 5,000 from the prior week’s revised figure of 232,000. This decline came against economist expectations, who had predicted claims would rise to…
-
Trinity Capital Posts Robust $519 Million in New Commitments for Q2
Trinity Capital Inc (NASDAQ:TRIN) shared an encouraging portfolio update for the first half and second quarter of 2025, reporting new commitments totaling $519 million in Q2 and $705 million for the six-month period. During the second quarter, the firm deployed roughly $365 million across various investments, including $296 million in secured loans, $68 million in…
-
DallasNews Shares Surge Over 200% After Hearst’s $14 Per Share Acquisition Announcement
Shares of DallasNews Corporation (NASDAQ:DALN) skyrocketed by 208% following news that media powerhouse Hearst plans to acquire the company for $14 per share in cash. This offer represents a substantial 219% premium over DallasNews’ closing price of $4.39 on July 9. Both companies’ boards have given unanimous approval, and the deal is anticipated to close…
-
Seven Hills Realty Trust Shares Dip Following Dividend Cut
Shares of Seven Hills Realty Trust (NASDAQ:SEVN) dropped 2.9% in pre-market trading Thursday after the company announced a reduction to its quarterly dividend payout. The real estate investment trust based in Newton, Massachusetts, lowered its quarterly distribution from $0.35 to $0.28 per share, marking a 20% decline. This adjustment sets the annualized dividend to $1.12…
-
Conagra Brands Stock Slides After Earnings Miss and Cautious 2026 Outlook
Shares of Conagra Brands, Inc. (NYSE:CAG) declined 3.8% on Thursday after the company delivered weaker-than-expected fourth-quarter results and issued a subdued forecast for fiscal 2026. For the quarter ended May, the Chicago-based packaged foods producer reported adjusted earnings per share of $0.56, below Wall Street’s consensus of $0.59. Revenue also came in lower than expected,…
-
FuelCell Energy Shares Rally on South Korean Data Center Deal
Shares of FuelCell Energy (NASDAQ:FCEL) jumped 12% following the announcement of a strategic collaboration with South Korean data center firm Inuverse to evaluate the use of up to 100 megawatts of fuel cell power systems. The two companies signed a Memorandum of Understanding (MOU) that could lead to the phased rollout of FuelCell’s technology at…
-
Air Industries Shares Skyrocket After Landing $5.4M B-52 Supply Contract
Shares of Air Industries Group (NYSE:AIRI) surged 65% after the company revealed it had secured a $5.4 million contract to produce key landing gear components for the U.S. Air Force’s B-52 bomber fleet. The contract, which includes manufacturing steering collar parts, marks Air Industries’ first involvement in the B-52 program and represents a new customer…
-
Simply Good Foods Lowers Full-Year Guidance After Mixed Q3 Results; Shares Dip
Shares of Simply Good Foods Co (NASDAQ:SMPL) slipped more than 3% in Thursday’s premarket session after the company posted mixed third-quarter results and tightened its full-year guidance for fiscal 2025. For Q3, the company reported earnings of $0.51 per share, slightly above Wall Street’s estimate of $0.50. However, revenue for the period came in at…
-
Klotho Neurosciences Shares Jump as FDA Grants Orphan Drug Status for ALS Therapy
Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) surged 22% following news that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s gene therapy candidate, KLTO-202, aimed at treating Amyotrophic Lateral Sclerosis (ALS). The newly designated treatment—a secreted-Klotho gene therapy utilizing a muscle-specific delivery system—is designed to target the neuromuscular junction,…